0001209191-23-043525.txt : 20230727
0001209191-23-043525.hdr.sgml : 20230727
20230727162136
ACCESSION NUMBER: 0001209191-23-043525
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230725
FILED AS OF DATE: 20230727
DATE AS OF CHANGE: 20230727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jerel Davis
CENTRAL INDEX KEY: 0001745958
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231118713
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-801-8100
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turnstone Biologics Corp.
CENTRAL INDEX KEY: 0001764974
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832909368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 347-897-5988
MAIL ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-07-25
0
0001764974
Turnstone Biologics Corp.
TSBX
0001745958
Jerel Davis
C/O TURNSTONE BIOLOGICS CORP.
9310 ATHENA CIRCLE, SUITE 300
LA JOLLA
CA
92037
1
0
1
0
0
Common Stock
2023-07-25
4
C
0
2528864
A
2528864
I
By Versant Venture Capital V, L.P.
Common Stock
2023-07-25
4
C
0
192458
A
192458
I
By Versant Venture Capital V (Canada) LP
Common Stock
2023-07-25
4
C
0
84313
A
84313
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Common Stock
2023-07-25
4
C
0
76067
A
76067
I
By Versant Affiliates Fund V, L.P.
Common Stock
2023-07-25
4
C
0
274990
A
274990
I
By Versant Vantage II, L.P.
Common Stock
2023-07-25
4
P
0
197458
12.00
A
2726322
I
By Versant Venture Capital V, L.P.
Common Stock
2023-07-25
4
P
0
15028
12.00
A
207486
I
By Versant Venture Capital V (Canada) LP
Common Stock
2023-07-25
4
P
0
6575
12.00
A
90888
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Common Stock
2023-07-25
4
P
0
5939
12.00
A
82006
I
By Versant Affiliates Fund V, L.P.
Series A Preferred Stock
2023-07-25
4
C
0
7897999
0.00
D
Common Stock
988832
0
I
By Versant Venture Capital V, L.P.
Series A Preferred Stock
2023-07-25
4
C
0
601077
0.00
D
Common Stock
75255
0
I
By Versant Venture Capital V (Canada) LP
Series A Preferred Stock
2023-07-25
4
C
0
263349
0.00
D
Common Stock
32971
0
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series A Preferred Stock
2023-07-25
4
C
0
237575
0.00
D
Common Stock
29744
0
I
By Versant Affiliates Fund V, L.P.
Series B-1 Preferred Stock
2023-07-25
4
C
0
3530789
0.00
D
Common Stock
442055
0
I
By Versant Venture Capital V, L.P.
Series B-1 Preferred Stock
2023-07-25
4
C
0
268711
0.00
D
Common Stock
33642
0
I
By Versant Venture Capital V (Canada) LP
Series B-1 Preferred Stock
2023-07-25
4
C
0
117730
0.00
D
Common Stock
14739
0
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series B-1 Preferred Stock
2023-07-25
4
C
0
106208
0.00
D
Common Stock
13297
0
I
By Versant Affiliates Fund V, L.P.
Series B-2 Preferred Stock
2023-07-25
4
C
0
7650043
0.00
D
Common Stock
957787
0
I
By Versant Venture Capital V, L.P.
Series B-2 Preferred Stock
2023-07-25
4
C
0
582206
0.00
D
Common Stock
72892
0
I
By Versant Venture Capital V (Canada) LP
Series B-2 Preferred Stock
2023-07-25
4
C
0
255081
0.00
D
Common Stock
31936
0
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series B-2 Preferred Stock
2023-07-25
4
C
0
230117
0.00
D
Common Stock
28810
0
I
By Versant Affiliates Fund V, L.P.
Series C Preferred Stock
2023-07-25
4
C
0
1119729
0.00
D
Common Stock
140190
0
I
By Versant Venture Capital V, L.P.
Series C Preferred Stock
2023-07-25
4
C
0
85217
0.00
D
Common Stock
10669
0
I
By Versant Venture Capital V (Canada) LP
Series C Preferred Stock
2023-07-25
4
C
0
37283
0.00
D
Common Stock
4667
0
I
By Versant Ophthalmic Affiliates Fund I, L.P.
Series C Preferred Stock
2023-07-25
4
C
0
33682
0.00
D
Common Stock
4216
0
I
By Versant Affiliates Fund V, L.P.
Series D Preferred Stock
2023-07-25
4
C
0
2196402
0.00
D
Common Stock
274990
0
I
By Versant Vantage II, L.P.
Each share of Series A Preferred Stock, Series B-1 Preferred Stock, Series, Series B-2 Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically convert into shares of Common Stock on a 7.9872 for 1 basis immediately prior to the closing of the Issuer's initial public offering for no additional consideration and had no expiration date.
Shares are held by Versant Venture Capital V, L.P. ("Versant V"). Versant Ventures V, LLC ("Versant V GP") is the sole general partner of Versant V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Versant V. The Reporting Persons disclaims beneficial ownership of the shares held by Versant V, except to the extent of his respective pecuniary interest therein.
Shares are held by Versant Venture Capital V (Canada) LP ("Canada V"). Versant Ventures V (Canada), L.P. ("Canada V GP") is the general partner of Canada V and Versant Ventures V GP-GP (Canada), Inc. ("Canada V GP-GP") is the sole general partner of Canada V GP. The Reporting Person, a member of the Issuer's board of directors, is a director of Canada V GP-GP and may be deemed to share voting and dispositive power over the shares held by Canada V. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein.
Shares are held by Versant Ophthalmic Affiliates Fund I, L.P. ("Ophthalmic"). Versant V GP is the sole general partner of Ophthalmic. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Ophthalmic. The Reporting Person disclaims beneficial ownership of the shares held by Ophthalmic, except to the extent of his respective pecuniary interest therein.
Shares are held by Versant Affiliates Fund V, L.P. ("Affiliates V"). Versant V GP is the sole general partner of Affiliates V. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Versant V GP and may be deemed to share voting and dispositive power over the shares held by Affiliates V. The Reporting Person disclaims beneficial ownership of the shares held by Affiliates, except to the extent of his respective pecuniary interest therein.
Shares held by Versant Vantage II, L.P. ("Vantage II"). Versant Vantage II GP, L.P. ("Vantage II GP") is the sole general partner of Vantage II and Versant Vantage II GP-GP, LLC (Vantage II GP-GP") is the sole general partner of Vantage II GP. The Reporting Person, a member of the Issuer's board of directors, is a managing director of Vantage II GP-GP and may be deemed to share voting and dispositive power over the shares held by Vantage II. The Reporting Person disclaims beneficial ownership of the shares held by Canada V, except to the extent of his respective pecuniary interest therein.
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
2023-07-27